CETP and coronary artery disorder: Different studies (the Framingham Offspring Study, the Veterans Affair HDL-c Intervention Trial and the WOSCOPS) have confirmed the association of CETP and a low CV risk in males [110,111,112], as has the AtheroGene Study, which, by evaluating 1211 patients with coronary artery disease (CAD) on follow-up, has demonstrated an association of the A allele of the CETP-629 variant with a reduced CV lethality [113].